glp 1 with dpp 4 GLP-1 receptor agonists and DPP-4 inhibitors Pathway, Pharmacodynamics The mechanism of action of
Description
Yalow RS, Berson SA
This ultimately leads to better blood sugar control, weight loss, and improved overall health for individuals with diabetes
9 Approved in 2005, exenatide was the first GLP-1 drug to be made available, and later modifications allowed for its extended release
Another involves stepping from 1mg to 1.5mg before jumping to 2mg, creating an intermediate tier that the clinical trials did not formally test but that some researchers implement based on tolerability assessments
We mentioned earlier
